Imagion Biosystems Ltd (IBX) - Net Assets

Latest as of June 2025: AU$-3.87 Million AUD ≈ $-2.74 Million USD

Based on the latest financial reports, Imagion Biosystems Ltd (IBX) has net assets worth AU$-3.87 Million AUD (≈ $-2.74 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$932.48K ≈ $659.79K USD) and total liabilities (AU$4.80 Million ≈ $3.40 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Imagion Biosystems Ltd to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$-3.87 Million
% of Total Assets	-414.57%
Annual Growth Rate	N/A
5-Year Change	-117.68%
10-Year Change	N/A
Growth Volatility	147.76

Imagion Biosystems Ltd - Net Assets Trend (2014–2024)

This chart illustrates how Imagion Biosystems Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Imagion Biosystems Ltd assets under control for the complete picture of this company's asset base.

Annual Net Assets for Imagion Biosystems Ltd (2014–2024)

The table below shows the annual net assets of Imagion Biosystems Ltd from 2014 to 2024. For live valuation and market cap data, see market cap of Imagion Biosystems Ltd.

Year	Net Assets	Change
2024-12-31	AU$-2.28 Million ≈ $-1.62 Million	+39.73%
2023-12-31	AU$-3.79 Million ≈ $-2.68 Million	-180.98%
2022-12-31	AU$4.68 Million ≈ $3.31 Million	-64.84%
2021-12-31	AU$13.31 Million ≈ $9.41 Million	+3.03%
2020-12-31	AU$12.91 Million ≈ $9.14 Million	+334.30%
2019-12-31	AU$2.97 Million ≈ $2.10 Million	-23.15%
2018-12-31	AU$3.87 Million ≈ $2.74 Million	-44.35%
2017-12-31	AU$6.95 Million ≈ $4.92 Million	-40.52%
2016-12-31	AU$11.69 Million ≈ $8.27 Million	+231.88%
2015-12-31	AU$-8.86 Million ≈ $-6.27 Million	-123.17%
2014-12-31	AU$-3.97 Million ≈ $-2.81 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Imagion Biosystems Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 6296755700.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	AU$62.54 Million	%
Other Comprehensive Income	AU$2.19 Million	%
Total Equity	AU$-2.28 Million	100.00%

Imagion Biosystems Ltd Competitors by Market Cap

The table below lists competitors of Imagion Biosystems Ltd ranked by their market capitalization.

Company	Market Cap
CU Medical Systems Inc KQ:115480	$5.90 Million
THG Holdings PLC LSE:THG	$5.90 Million
Viji Finance Limited NSE:VIJIFIN	$5.90 Million
HIGH QUALITY FOOD F:L24	$5.90 Million
Eko Export SA WAR:EEX	$5.90 Million
Macarthur Minerals Ltd AU:MIO	$5.90 Million
Enlitic Inc AU:ENL	$5.90 Million
KWANGJIN WINTEC CO. Ltd KQ:090150	$5.89 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Imagion Biosystems Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from -3,788,047 to -2,282,980, a change of 1,505,067.
Net loss of 2,066,957 reduced equity.
Share repurchases of 3,125,230 reduced equity.
New share issuances of 3,125,226 increased equity.
Other comprehensive income decreased equity by 2,736,036.
Other factors increased equity by 6,308,064.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	AU$-2.07 Million	-90.54%
Share Repurchases	AU$3.13 Million	-136.89%
Share Issuances	AU$3.13 Million	+136.89%
Other Comprehensive Income	AU$-2.74 Million	-119.84%
Other Changes	AU$6.31 Million	+276.31%
Total Change	AU$-	%

Book Value vs Market Value Analysis

This analysis compares Imagion Biosystems Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2014-12-31	AU$-193.74	AU$0.02	x
2015-12-31	AU$-432.37	AU$0.02	x
2016-12-31	AU$0.11	AU$0.02	x
2017-12-31	AU$0.04	AU$0.02	x
2018-12-31	AU$0.02	AU$0.02	x
2019-12-31	AU$0.33	AU$0.02	x
2020-12-31	AU$0.69	AU$0.02	x
2021-12-31	AU$0.51	AU$0.02	x
2022-12-31	AU$0.17	AU$0.02	x
2023-12-31	AU$-0.12	AU$0.02	x
2024-12-31	AU$-0.05	AU$0.02	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Imagion Biosystems Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.00%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -77.56%
• Asset Turnover: 0.95x
• Equity Multiplier: 0.00x
Recent ROE (0.00%) is above the historical average (-68.06%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	0.00%	-41159.99%	0.02x	0.00x	AU$-2.12 Million
2015	0.00%	-80124.99%	0.01x	0.00x	AU$-3.51 Million
2016	-8.85%	-8620641.67%	0.00x	1.04x	AU$-2.20 Million
2017	-112.11%	-38775.26%	0.00x	1.10x	AU$-8.49 Million
2018	-215.75%	-4359.67%	0.04x	1.34x	AU$-8.73 Million
2019	-115.44%	-835.46%	0.08x	1.64x	AU$-3.73 Million
2020	-41.54%	-2607.47%	0.01x	1.09x	AU$-6.66 Million
2021	-45.28%	-2587.21%	0.02x	1.06x	AU$-7.36 Million
2022	-209.71%	-2071.95%	0.05x	2.13x	AU$-10.28 Million
2023	0.00%	-1151.86%	0.24x	0.00x	AU$-12.10 Million
2024	0.00%	-77.56%	0.95x	0.00x	AU$-1.84 Million

Industry Comparison

This section compares Imagion Biosystems Ltd's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

Industry: Diagnostics & Research
Average net assets among peers: $287,738,369
Average return on equity (ROE) among peers: -34.30%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Imagion Biosystems Ltd (IBX)	AU$-3.87 Million	0.00%	N/A	$5.90 Million
Australian Clinical Labs Ltd (ACL)	$14.12 Million	-170.17%	7.56x	$256.90 Million
Bcal Diagnostics Ltd (BDX)	$9.64 Million	-35.12%	0.10x	$21.65 Million
Cryosite Ltd (CTE)	$3.87 Million	-25.46%	0.05x	$39.72 Million
Genetic Signatures Ltd (GSS)	$16.49 Million	-16.20%	0.07x	$14.14 Million
Genetic Technologies Ltd (GTG)	$20.83 Million	-26.20%	0.16x	$4.01 Million
Healius Ltd (HLS)	$2.50 Billion	3.13%	0.53x	$254.32 Million
Integral Diagnostics Ltd (IDX)	$2.54 Million	127.10%	0.00x	$585.79 Million
Inoviq Ltd (IIQ)	$2.83 Million	-115.42%	0.16x	$32.37 Million
Microba Life Sciences Ltd (MAP)	$14.94 Million	-50.37%	0.24x	$32.75 Million

About Imagion Biosystems Ltd

AU:IBX Australia Diagnostics & Research

Market Cap

$5.90 Million

AU$8.34 Million AUD

Market Cap Rank

#28035 Global

#1515 in Australia

Share Price

AU$0.02

Change (1 day)

+21.43%

52-Week Range

AU$0.01 - AU$0.05

All Time High

AU$8.60